These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 32706122

  • 1. Cost-effectiveness of botulinum neurotoxin A versus surgery for drooling: a randomized clinical trial.
    Bekkers S, van Ulsen KJ, M M Adang E, R T Scheffer A, J A van den Hoogen F.
    Dev Med Child Neurol; 2020 Nov; 62(11):1302-1308. PubMed ID: 32706122
    [Abstract] [Full Text] [Related]

  • 2. Submandibular duct ligation after botulinum neurotoxin A treatment of drooling in children with cerebral palsy.
    Bekkers S, Pruijn IMJ, Van Hulst K, Delsing CP, Erasmus CE, Scheffer ART, Van Den Hoogen FJA.
    Dev Med Child Neurol; 2020 Jul; 62(7):861-867. PubMed ID: 32149393
    [Abstract] [Full Text] [Related]

  • 3. Surgery versus botulinum neurotoxin A to reduce drooling and improve daily life for children with neurodevelopmental disabilities: a randomized controlled trial.
    Bekkers S, Pruijn IMJ, van der Burg JJW, van Hulst K, Kok SE, Delsing CP, Scheffer ART, van den Hoogen FJA.
    Dev Med Child Neurol; 2021 Nov; 63(11):1351-1359. PubMed ID: 33997959
    [Abstract] [Full Text] [Related]

  • 4. Submandibular gland botulinum neurotoxin A injection for predicting the outcome of submandibular duct relocation in drooling: a retrospective cohort study.
    Kok SE, van Valenberg HFJP, van Hulst K, Jongerius P, Erasmus CE, van den Hoogen FJA.
    Dev Med Child Neurol; 2019 Nov; 61(11):1323-1328. PubMed ID: 30854648
    [Abstract] [Full Text] [Related]

  • 5. Randomized controlled trial comparing botulinum vs surgery for drooling in neurodisabilities.
    Bekkers S, Delsing CP, Kok SE, van Hulst K, Erasmus CE, Scheffer ART, van den Hoogen FJA.
    Neurology; 2019 Mar 12; 92(11):e1195-e1204. PubMed ID: 30728311
    [Abstract] [Full Text] [Related]

  • 6. Effect of botulinum toxin in the treatment of drooling: a controlled clinical trial.
    Jongerius PH, van den Hoogen FJ, van Limbeek J, Gabreëls FJ, van Hulst K, Rotteveel JJ.
    Pediatrics; 2004 Sep 12; 114(3):620-7. PubMed ID: 15342830
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. An evaluation of predictors for success of two-duct ligation for drooling in neurodisabilities.
    Bekkers S, van Hulst K, Erasmus CE, Delsing CP, Scheffer ART, van den Hoogen FJA.
    J Neurol; 2020 May 12; 267(5):1508-1515. PubMed ID: 32025794
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Botulinum toxin effect on salivary flow rate in children with cerebral palsy.
    Jongerius PH, Rotteveel JJ, van Limbeek J, Gabreëls FJ, van Hulst K, van den Hoogen FJ.
    Neurology; 2004 Oct 26; 63(8):1371-5. PubMed ID: 15505151
    [Abstract] [Full Text] [Related]

  • 12. Factors in the Efficacy, Safety, and Impact on Quality of Life for Treatment of Drooling with Botulinum Toxin Type A in Patients with Cerebral Palsy.
    Gonzalez-L MD, Martinez C, Bori Y Fortuny I, Suso-Vergara S.
    Am J Phys Med Rehabil; 2017 Feb 26; 96(2):68-76. PubMed ID: 28099276
    [Abstract] [Full Text] [Related]

  • 13. Repeated onabotulinum neurotoxin A injections for drooling in children with neurodisability.
    Bekkers S, Leow TY, Van Hulst K, Orriëns LB, Scheffer AR, Van Den Hoogen FJ.
    Dev Med Child Neurol; 2021 Aug 26; 63(8):991-997. PubMed ID: 33772779
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Onabotulinum Toxin A (BoNT-A) for Drooling in Children: A Systematic Review and Meta-Analysis.
    Oad H, Maltezeanu A, da Silva SD, Daniel SJ.
    Laryngoscope; 2024 Jul 26; 134(7):3012-3017. PubMed ID: 38294288
    [Abstract] [Full Text] [Related]

  • 18. Changes in severity and impact of drooling after submandibular gland botulinum neurotoxin A injections in children with neurodevelopmental disabilities.
    Van Hulst K, Van Der Burg JJ, Jongerius PH, Geurts AC, Erasmus CE.
    Dev Med Child Neurol; 2020 Mar 26; 62(3):354-362. PubMed ID: 31729034
    [Abstract] [Full Text] [Related]

  • 19. Effectiveness and safety of botulinum toxin in comparison with surgery for drooling in paediatric patients with neurological disorders: a systematic review.
    Silva JPS, Faria LV, Almeida RC, Medeiros YL, Guimarães LDA.
    Br J Oral Maxillofac Surg; 2022 Jun 26; 60(5):e691-e701. PubMed ID: 35227530
    [Abstract] [Full Text] [Related]

  • 20. Botulinum toxin type B for sialorrhoea in children with cerebral palsy: a randomized trial comparing three doses.
    Basciani M, Di Rienzo F, Fontana A, Copetti M, Pellegrini F, Intiso D.
    Dev Med Child Neurol; 2011 Jun 26; 53(6):559-64. PubMed ID: 21413974
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.